Conversely, cIAP2 exhibits a unique therapeutic mechanism distinct from that of cIAP1 in the context of RA, highlighting the differential contribution of these proteins to disease pathology and treatment (88). The gene discussed is BIRC3; the disease is rheumatoid arthritis.